In vitro biodistribution studies on clinically approved FGFR inhibitors ponatinib, nintedanib, erlotinib and the investigational inhibitor KP2692

Dömötör Orsolya and Mathuber Marlene and Kowol Christian R.: In vitro biodistribution studies on clinically approved FGFR inhibitors ponatinib, nintedanib, erlotinib and the investigational inhibitor KP2692.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 192. ISSN 0928-0987 (2024)

[thumbnail of EJPS_2023.pdf] Text
EJPS_2023.pdf - Published Version

Download (2MB)
Creators:
Dömötör Orsolya MTMT
Mathuber Marlene
Kowol Christian R.
Item Type: Journal Article
Journal or Publication Title: EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Date: 2024
Volume: 192
Number of Pages: 10
Publication identifier: 106651
ISSN: 0928-0987
Faculty/Unit: Faculty of Science and Informatics
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 34415568
DOI azonosító: https://doi.org/10.1016/j.ejps.2023.106651
Date Deposited: 2023. Dec. 06. 08:34
Last Modified: 2023. Dec. 06. 08:34
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/29004
Web of Science® Times Cited: 2 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year